Security
TLSI · TriSalus Life Sciences, Inc.
TLSINASDAQCommon stockCurrentCIK 1826667Updated Sep 24, 2026
Name history
MedTech Acquisition Corp · through Aug 10, 2023MedTech Acquisition Corporation · through Oct 29, 2020
TLSI price & chart
Loading TradingView…
NASDAQ:TLSI on TradingView ↗In the news
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI ↗
Recent filings
Other Events
Items 8.01, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
4 filing
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 35,331,000Source | 23,971,000Source | 25,725,000Source | 20,187,776Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 20,439,000Source | 8,525,000Source | 11,777,000Source | 153,563Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 6,558,000Source | 5,087,000Source | 3,554,000Source | — |
| Inventory, NetUSD | 3,077,000Source | 4,048,000Source | 2,545,000Source | — |
| Assets, CurrentUSD | 32,244,000Source | 20,669,000Source | 20,862,000Source | 359,892Source |
| Operating Lease, Right-of-Use AssetUSD | 861,000Source | 1,210,000Source | 1,179,000Source | — |
| Other Assets, NoncurrentUSD | 418,000Source | 423,000Source | 466,000Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 69,192,000Source | 49,865,000Source | 51,663,000Source | 13,654,332Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | — |
| Common Stock, Value, IssuedUSD | 4,000Source | 3,000Source | 2,000Source | — |
| Additional Paid in CapitalUSD | 296,718,000Source | 253,652,000Source | 222,437,000Source | — |
| Retained Earnings (Accumulated Deficit)USD | -330,583,000Source | -279,549,000Source | -248,377,000Source | -13,267,211Source |
| Stockholders' Equity Attributable to ParentUSD | -33,861,000Source | -25,894,000Source | -25,938,000Source | -13,266,586Source |
| Liabilities and EquityUSD | 35,331,000Source | 23,971,000Source | 25,725,000Source | 20,187,776Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 11,499,000Source | 10,228,000Source | 14,687,000Source | 2,501,998Source |
| Operating Lease, Liability, CurrentUSD | 128,000Source | 136,000Source | 275,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | 1,186,000Source | 1,311,000Source | 1,156,000Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 8,096,000Source | 7,355,000Source | 10,556,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 33,046,000Source | 22,084,000Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | 5,539,079Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 9,131,000Source | 5,441,000Source | 1,402,000Source | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 1,634,000Source | 1,719,000Source | 1,979,000Source | — |
| Increase (Decrease) in InventoriesUSD | -971,000Source | 1,503,000Source | 1,073,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -18,012,000Source | -40,843,000Source | -50,045,000Source | -2,736,994Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -838,000Source | -345,000Source | -2,121,000Source | 233,198,137Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 918,000Source | 345,000Source | 588,000Source | — |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | — | — | 232,371,273Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 30,764,000Source | 37,936,000Source | 54,629,000Source | -230,508,464Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 11,914,000Source | -3,252,000Source | 2,463,000Source | -47,321Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 20,789,000Source | 8,875,000Source | 12,127,000Source | 153,563Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 3,697,000Source | 1,750,000Source | — | — |
| Income Taxes Paid, NetUSD | 16,000Source | 18,000Source | 14,000Source | 543,000Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance CostsUSD | 1,049,000Source | 612,000Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | 18,000Source | — |
| DepreciationUSD | 600,000Source | 700,000Source | 684,000Source | — |
| Derivative, Gain (Loss) on Derivative, NetUSD | -4,086,000Source | -2,777,000Source | -10,855,000Source | — |
| Gain (Loss) on Sale of DerivativesUSD | — | 0Source | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -120,000Source | -23,000Source | -44,000Source | — |
| General and Administrative ExpenseUSD | 21,458,000Source | 17,966,000Source | 23,512,000Source | 2,746,125Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | 190,000Source | — |
| Income Tax Expense (Benefit)USD | 7,000Source | 6,000Source | 9,000Source | 570,854Source |
| InterestExpenseNonoperatingUSD | 5,544,000Source | 3,090,000Source | — | — |
| Investment Income, InterestUSD | 555,000Source | 404,000Source | 431,000Source | 3,018,726Source |
| Net Income (Loss) Attributable to ParentUSD | -39,227,000Source | -30,045,000Source | -59,038,000Source | 5,539,079Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -69,690,000Source | -33,233,000Source | -63,277,000Source | — |
| Nonoperating Income (Expense)USD | — | — | — | 8,856,058Source |
| Other Nonoperating Income (Expense)USD | -456,000Source | -312,000Source | -379,000Source | — |
| Payments for Repurchase of WarrantsUSD | — | 0Source | 20,000Source | — |
| Proceeds from Issuance of Common StockUSD | 22,000,000Source | 15,537,000Source | — | — |
| Proceeds from Noncontrolling InterestsUSD | — | — | — | 82,741Source |
| Proceeds from Stock Options ExercisedUSD | 510,000Source | 76,000Source | 179,000Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 45,151,000Source | 29,431,000Source | 18,511,000Source | — |
| Cost of RevenueUSD | 6,965,000Source | 4,103,000Source | 2,605,000Source | — |
| Operating Income (Loss)USD | -26,946,000Source | -36,165,000Source | -54,150,000Source | -2,746,125Source |
| Other Nonoperating Income (Expense)USD | -456,000Source | -312,000Source | -379,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -39,220,000Source | -30,039,000Source | -59,029,000Source | 6,109,933Source |
| Income Tax Expense (Benefit)USD | 7,000Source | 6,000Source | 9,000Source | 570,854Source |
| Net Income (Loss) Attributable to ParentUSD | -39,227,000Source | -30,045,000Source | -59,038,000Source | 5,539,079Source |
| Earnings Per Share, BasicUSD per share | -1.84Source | -1.31Source | -6.73Source | — |
| Earnings Per Share, DilutedUSD per share | -1.84Source | -1.31Source | -6.73Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 37,897,785Source | 25,331,753Source | 9,395,748Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 37,897,785Source | 25,331,753Source | 9,395,748Source | — |
| Interest Expense (non-operating)USD | 5,544,000Source | 3,090,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | — | 18,000Source | — |
| Business Combination, Acquisition Related CostsUSD | — | — | — | 40,000,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 626,000Source | 744,000Source | 702,000Source | — |
| General and Administrative ExpenseUSD | 21,458,000Source | 17,966,000Source | 23,512,000Source | 2,746,125Source |
| Gross ProfitUSD | 38,186,000Source | 25,328,000Source | 15,906,000Source | — |
| Interest ExpenseUSD | — | — | 16,000Source | — |
| Investment Income, InterestUSD | 555,000Source | 404,000Source | 431,000Source | 3,018,726Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -69,690,000Source | -33,233,000Source | -63,277,000Source | — |
| Nonoperating Income (Expense)USD | — | — | — | 8,856,058Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | 0Source | 3,188,000Source | 1,258,000Source | — |
| Research and Development ExpenseUSD | 14,965,000Source | 17,688,000Source | 29,510,000Source | — |
| Selling and Marketing ExpenseUSD | 28,709,000Source | 25,839,000Source | 17,034,000Source | — |